Anti-CD22 CAR-T combined with anti-CD19 CAR-T cells in the treatment of relapsed or refractory acute B lymphocytic leukemia with severe cytokine release syndrome: two cases report and literature review.
10.3760/cma.j.issn.0253-2727.2019.09.016
- Author:
Li Li GAO
1
;
Liang HUANG
;
Na WANG
;
Gao Xiang WANG
;
Xiao Xi ZHOU
;
Tong Juan LI
;
Zhen Ya HONG
;
Li MENG
;
Jian Feng ZHOU
Author Information
1. Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology & Immunotherapy Research Center for Hematologic Diseases, Wuhan 430030, China.
- Publication Type:Review
- MeSH:
Antigens, CD19;
Automobiles;
Cytokine Release Syndrome/complications*;
Humans;
Immunotherapy, Adoptive;
Leukemia, B-Cell/complications*;
Receptors, Antigen, T-Cell;
Sialic Acid Binding Ig-like Lectin 2;
T-Lymphocytes
- From:
Chinese Journal of Hematology
2019;40(9):780-782
- CountryChina
- Language:Chinese
